Share this

References:

  1. Food and Drug Administration. Center for Biologics Evaluation and Research (CBER). CBER clinical review of studies submitted in support of licensure
    of ProQuad. https://www.fda.gov/media/165978/download. Accessed July 2026.
  2. Bernstein HH, Eves K, Campbell K, et al. Comparison of the safety and immunogenicity of a refrigerator-stable versus a frozen formulation of ProQuad
    (measles, mumps, rubella, and varicella virus vaccine live). Pediatrics. 2007;119(6):e1299–e1305.

AE-QDX-00012 | Exp: 25 July 2028